Transcriptional Inhibition of Host Viral Entry Proteins as a Therapeutic Strategy for SARS-CoV-2
Xinchen Wang(Columbia University Irving Medical Center), David B. Goldstein(Duke University), Joshua Motelow(Morgan Stanley Children's Hospital), Ryan S. Dhindsa(Baylor College of Medicine), Gundula Povysil(Bridgepoint (United States)), Joseph Hostyk(A&G Pharmaceutical (United States)), Anthony W. Zoghbi(Baylor College of Medicine)
Cited by 49
Related Papers
Genome-wide mega-analysis identifies 16 loci and highlights diverse biological mechanisms in the common epilepsies
|Nature Communications|2018|517
Ultra-Rare Genetic Variation in the Epilepsies: A Whole-Exome Sequencing Study of 17,606 Individuals
|The American Journal of Human Genetics|2019|310
Rare-variant collapsing analyses for complex traits: guidelines and applications
|Nature Reviews Genetics|2019|241
Ultra-rare genetic variation in common epilepsies: a case-control sequencing study
|The Lancet Neurology|2017|234